Cargando…
免疫检查点TIGIT在肺癌免疫治疗中的研究进展
T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain (TIGIT) is a newly discovered immune checkpoint molecule, mainly expressed on the surface of T cells and natural killer (NK) cells. By binding to cluster of differentiation 155 (CD155) and other ligan...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720676/ https://www.ncbi.nlm.nih.gov/pubmed/36419396 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.45 |
Ejemplares similares
-
免疫检查点抑制剂在小细胞肺癌治疗中的临床研究进展
Publicado: (2019) -
免疫检查点抑制剂在小细胞肺癌中的临床研究进展
Publicado: (2017) -
肺癌免疫检查点抑制剂的联合治疗研究进展
Publicado: (2020) -
PD-1/PD-L1免疫检查点抑制剂在肺癌中的研究进展
Publicado: (2019) -
免疫检查点抑制剂在小细胞肺癌治疗中的应用与临床试验进展
Publicado: (2021)